Diabetes Board decisions

The Board granted service connection for diabetes mellitus, a bilateral foot disability (other than bilateral plantar fasciitis), to include gout, right hand and left hand disabilities, as well as a thyroid disorder, all secondary to the Veteran's service-connected obstructive sleep apnea. The Board also granted a TDIU from September 25, 2020.

The Board denied the Veteran's claim for service connection for diabetes mellitus type II, finding that there was no evidence of exposure to herbicide agents and that the condition did not have its onset in or is otherwise related to his active duty service.

The appeal is remanded to correct a pre-decisional duty to assist error by the AOJ.

The Board denied service connection for diabetes mellitus and remanded the claim for a left ankle Achilles tendon rupture status post-surgery with ankle sprain.

The Board granted service connection for diabetes mellitus, type II as secondary to a bilateral knee disability and an effective date of October 14, 2020 for the award of service connection for migraine headaches.

The Board denied service connection for hypertension and remanded the claim for diabetes mellitus, type II under 38 U.S.C. § 1151.

The Board denied service connection for bilateral tinnitus and bilateral hearing loss due to the lack of a current diagnosis, and remanded claims for diabetes mellitus type II and hypertension associated with herbicide exposure for further development.

The Board denied the Veteran's claim for special monthly compensation (SMC) based on the need for aid and attendance or housebound status due to his service-connected disabilities not meeting the criteria.

The Board granted a rating of 50 percent for major depressive disorder with alcohol use disorder and cognitive impairment from May 1, 2017 to December 10, 2019; denied a rating in excess of 70 percent from December 11, 2019 to February 6, 2023. The Board granted ratings of 20 percent for right and left lower extremity sciatic nerve peripheral neuropathy from May 1, 2017 to February 6, 2023; denied a rating in excess of 20 percent on and after February 7, 2023. The Board granted an initial 10 percent rating for hypertension effective August 10, 2022.

The Board of Veterans' Appeals (Board) remands the claims for service connection for various conditions, including an acquired psychiatric disorder, aortic tear, cataracts, diabetes mellitus, GERD, and hearing loss.

The Board granted service connection for diabetes mellitus, type II based on the Veteran's presumed exposure to herbicide agents in Thailand under the PACT Act.

The Board denied the veteran's claims for increased ratings and service connection, as well as a TDIU.

The Board remands the claim for a higher disability rating for diabetes mellitus type 2 due to the Veteran's failure to attend a scheduled VA examination without good cause, which was determined to be a pre-decisional duty-to-assist error.

The Board remands the claims for an increased rating of diabetes mellitus II and entitlement to TDIU prior to June 15, 2018, due to a lack of compliance with previous remand directives.

The Board granted service connection for diabetes mellitus type II and hypertension, as secondary to the service-connected left ankle strain.

The Board granted service connection for obstructive sleep apnea (OSA) as it was caused by the Veteran's service-connected acquired psychiatric disorder. The other claims for type 2 diabetes mellitus, hypertension, and irritable bowel syndrome were remanded for further examination.

The Board granted service connection for diabetes mellitus type II, finding that the Veteran's service-connected depressive disorder caused his obesity, which in turn led to the development of diabetes.

The appeal for service connection for sinusitis was denied, while the other claims were remanded for further development.

The Board denied the veteran's claims for higher ratings and earlier effective dates, except for an earlier effective date for service connection of lower extremity peripheral neuropathy.

The Board remands the claims for service connection for diabetes mellitus and prostate cancer due to insufficient evidence regarding the Veteran's exposure to herbicide agents in the Korean DMZ.